Enzutix 40 mg Capsule
PDF Leaflet Revision Date: 24 January 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of metastatic castration-resistant prostate cancer in adult men.
Dosage (summary)
160 mg (4 x 40 mg capsules) once daily.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in women; potential harm to unborn child.
Key Drug Interactions
- CYP2C8 inhibitors
- CYP3A4 inhibitors
- Warfarin
Contraindications
- Hypersensitivity to enzalutamide
- Not for use in women
Common side effects
- Fatigue
- Hot flush
- Headache
- Fractures
- Hypertension
Counselling Points
- Swallow capsules whole with water
- Use condoms during treatment
- Monitor for seizures
Serious warnings
- Risk of seizure
- Posterior reversible encephalopathy syndrome
On This Page
Loading package insert…
Medinsert AI
Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
